Di Giacomo Claudia, Acquaviva Rosaria, Lanteri Raffaele, Licata Francesca, Licata Antonio, Vanella Angelo
Department of Biochemistry, Medical Chemistry and Molecular Biology, University of Catania, 95125, Catania, Italy.
Exp Biol Med (Maywood). 2003 May;228(5):525-8. doi: 10.1177/15353702-0322805-17.
Reactive oxygen species (ROS) could be important causative agents of a number of human diseases, including cancer. Thus, antioxidants, which control the oxidative stress state, represent a major line of defense regulating overall health. Human plasma contains many different nonenzymatic antioxidants. Because of their number, it is difficult to measure each of these different antioxidants separately. In addition, the antioxidant status in human plasma is dynamic and may be affected by many factors. Thus, the relationship between nonenzymatic antioxidant capacity of plasma and levels of well-known markers of oxidative stress (oxidized proteins, lipid hydroperoxides, decreases in thiol groups) better reflects health status. The present study considers antioxidant capacity and oxidative stress in human plasma of patients with colon cancer or precancerous lesions, as well as before and after surgical removal of tumors and/or chemo/radiation therapy. Healthy blood donors were used as controls. Colon cancer patients demonstrated a significant decrease in nonproteic antioxidant status and in total thiol groups with respect to healthy controls, whereas oxidized proteins and lipid hydroperoxide levels were significantly increased. In patients with precancerous lesions, the only unmodified parameter was the thiol group level. After surgery, the levels of oxidized proteins, lipid hydroperoxides, and total thiol groups were restored to those seen in healthy subjects, whereas nonproteic antioxidant capacity remained unmodified from that determined before surgery. Conversely, chemo/radiation therapy increased both nonproteic antioxidant capacity and levels of oxidized proteins and lipid hydroperoxides and significantly decreased total thiol groups. These results further support the hypothesis that oxidative stress correlates to the risk of some forms of cancer, not only in the initial stages but also during progression.
活性氧(ROS)可能是包括癌症在内的多种人类疾病的重要致病因素。因此,控制氧化应激状态的抗氧化剂是调节整体健康的主要防线。人体血浆中含有许多不同的非酶抗氧化剂。由于其数量众多,很难分别测量每一种不同的抗氧化剂。此外,人体血浆中的抗氧化状态是动态的,可能会受到多种因素的影响。因此,血浆中非酶抗氧化能力与氧化应激的知名标志物(氧化蛋白、脂质氢过氧化物、硫醇基团减少)水平之间的关系能更好地反映健康状况。本研究考察了结肠癌或癌前病变患者以及肿瘤手术切除和/或放化疗前后人体血浆中的抗氧化能力和氧化应激情况。健康献血者作为对照。与健康对照组相比,结肠癌患者的非蛋白质抗氧化状态和总硫醇基团显著降低,而氧化蛋白和脂质氢过氧化物水平显著升高。在癌前病变患者中,唯一未改变的参数是硫醇基团水平。手术后,氧化蛋白、脂质氢过氧化物和总硫醇基团水平恢复到健康受试者的水平,而非蛋白质抗氧化能力与手术前测定的水平相比没有变化。相反,放化疗增加了非蛋白质抗氧化能力以及氧化蛋白和脂质氢过氧化物水平,并显著降低了总硫醇基团。这些结果进一步支持了以下假设:氧化应激不仅在某些癌症的初始阶段,而且在进展过程中都与癌症风险相关。